Wall Street brokerages expect Acadia Healthcare Company Inc (NASDAQ:ACHC) to report earnings per share (EPS) of $0.47 for the current quarter, according to Zacks. Seven analysts have issued estimates for Acadia Healthcare’s earnings, with estimates ranging from $0.32 to $0.51. Acadia Healthcare reported earnings per share of $0.61 during the same quarter last year, which suggests a negative year-over-year growth rate of 23%. The company is expected to announce its next earnings report on Wednesday, February 20th.

On average, analysts expect that Acadia Healthcare will report full year earnings of $2.35 per share for the current fiscal year, with EPS estimates ranging from $2.25 to $2.55. For the next financial year, analysts expect that the company will post earnings of $2.56 per share, with EPS estimates ranging from $2.28 to $2.74. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side research analysts that that provide coverage for Acadia Healthcare.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Monday, November 5th. The company reported $0.55 earnings per share for the quarter, missing analysts’ consensus estimates of $0.64 by ($0.09). The business had revenue of $760.90 million during the quarter, compared to analyst estimates of $760.46 million. Acadia Healthcare had a net margin of 7.43% and a return on equity of 7.71%. The company’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.58 EPS.

A number of brokerages recently weighed in on ACHC. Citigroup dropped their price objective on shares of Acadia Healthcare from $46.00 to $43.00 and set a “buy” rating for the company in a report on Wednesday. Jefferies Financial Group lifted their price objective on shares of Acadia Healthcare from $44.00 to $47.00 and gave the company a “buy” rating in a report on Tuesday, July 31st. ValuEngine upgraded shares of Acadia Healthcare from a “strong sell” rating to a “sell” rating in a report on Thursday, July 26th. BMO Capital Markets cut shares of Acadia Healthcare from an “outperform” rating to a “market perform” rating and set a $45.00 price objective for the company. in a report on Wednesday, August 1st. Finally, BidaskClub upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating in a report on Thursday, September 6th. Nine research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The company has an average rating of “Hold” and an average target price of $43.10.

Shares of ACHC stock opened at $37.49 on Thursday. The company has a quick ratio of 1.26, a current ratio of 1.26 and a debt-to-equity ratio of 1.19. The company has a market capitalization of $3.70 billion, a P/E ratio of 16.30, a price-to-earnings-growth ratio of 1.82 and a beta of 0.22. Acadia Healthcare has a fifty-two week low of $26.92 and a fifty-two week high of $45.35.

In related news, Director Reeve B. Waud sold 41,865 shares of Acadia Healthcare stock in a transaction that occurred on Thursday, November 1st. The shares were sold at an average price of $45.00, for a total value of $1,883,925.00. Following the completion of the transaction, the director now owns 14,213 shares in the company, valued at $639,585. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.50% of the stock is owned by insiders.

Institutional investors have recently modified their holdings of the stock. Alpine Woods Capital Investors LLC purchased a new stake in shares of Acadia Healthcare during the 2nd quarter worth approximately $153,000. New Jersey Better Educational Savings Trust purchased a new stake in shares of Acadia Healthcare during the 2nd quarter worth approximately $205,000. Bbva Compass Bancshares Inc. purchased a new stake in shares of Acadia Healthcare during the 2nd quarter worth approximately $259,000. Jefferies Group LLC purchased a new stake in shares of Acadia Healthcare during the 3rd quarter worth approximately $225,000. Finally, BNP Paribas Arbitrage SA lifted its position in shares of Acadia Healthcare by 118.3% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 8,425 shares of the company’s stock worth $345,000 after buying an additional 4,566 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.

Featured Story: Asset Allocation and Your Retirement

Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.